HLA-A*25 antigen

Also Known As:

HLA A25; HLA-A25

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4
      - Histocompatibility Antigens Class I: 1944
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4
      - Histocompatibility Antigens Class I: 1944
        HLA-A Antigens: 2452
        HLA-A*25 antigen: 4

Experts

1.	Gao, M: 1 article (09/2006)
2.	Ge, H S: 1 article (09/2006)
3.	Liang, Y H: 1 article (09/2006)
4.	Liu, H S: 1 article (09/2006)
5.	Wang, J Y: 1 article (09/2006)
6.	Xia, Q: 1 article (09/2006)
7.	Yang, S: 1 article (09/2006)
8.	Zhang, X J: 1 article (09/2006)
9.	Zhou, W M: 1 article (09/2006)

Related Diseases

1.	Vitiligo 09/01/2006 - "The frequencies of HLA-A25-DQA10302-DQB10503 and HLA-A30-DQA10302-DQB10303 were higher in childhood vitiligo than in adult vitiligo, and the frequency of HLA-A25-B13-DQB10303-Cw0602 was shown to be associated with adult vitiligo but not childhood vitiligo. " 09/01/2006 - "The extended haplotypes HLA-A25-B13-Cw0602, HLA-A25-B27-Cw0602, HLA-DQA10302-DQB10303-Cw0602 and HLA-B13-DQB10303-Cw0602 were found to be associated with all types of vitiligo in Chinese Hans, whereas the frequency of HLA-A25-Cw0602-DQA10302 was significantly increased in generalized vitiligo but not in localized vitiligo. " 09/01/2006 - "Two-locus haplotypes including HLA-A25-B13, HLA-A25-B27, HLA-A25-Cw0602, HLA-A25-DQA10302, HLA-A25-DQA10601, HLA-A25-DQB10303, HLA-B13-Cw0602, HLA-B13-DQA10302, HLA-B13-DQA10601, HLA-B27-Cw0602, HLA-B27-DQA10302, HLA-B27-DQA10601, HLA-B27-DQB10303, HLA-B27-DQB10503, HLA-Cw0602-DQA10302, HLA-Cw0602-DQA10601, HLA-Cw0602-DQB10303, HLA-Cw0602-DQB10503 and HLA-DQA10302-DQB1*0503 were associated with all types of vitiligo in Chinese Hans. "
2.	Tetanus 01/01/1994 - "The examination of 99 children immunized with adsorbed DPT vaccine revealed that the intensity of immune response to the diphtheria and tetanus components of the preparation were linked with a number of genetic markers (respectively, HLA-A9, B35, etc.; HLA-A25, B8, etc.) and their combinations. "
3.	Rheumatic Diseases (Rheumatism) 12/01/1981 - "We conclude that the increased incidence of rheumatic disease in persons with C2D deficiency is multifactorial and requires environmental factors or other hereditary factors unrelated to the HLA-A25, B18, DR2 haplotype. "
4.	Heart Failure 03/01/1982 - "(a) a "surgical" group which required cardiac surgery and (b) a "non-surgical" group in which cardiac failure was absent or could be easily controlled by medical therapy, the difference between the two groups was also not of statistical significance, though there was a higher incidence of HLA-A10 (which includes HLA-A25 and A26) in the "non-surgical" group. "
5.	Diphtheria 01/01/1994 - "The examination of 99 children immunized with adsorbed DPT vaccine revealed that the intensity of immune response to the diphtheria and tetanus components of the preparation were linked with a number of genetic markers (respectively, HLA-A9, B35, etc.; HLA-A25, B8, etc.) and their combinations. "

Related Drugs and Biologics

1.	HLA-B13 Antigen
2.	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)
3.	Genetic Markers (Genetic Marker)
4.	HLA-A*30 antigen
5.	HLA-DQA1 antigen (HLA DQA1)
6.	HLA-A10 antigen
7.	HLA-A9 antigen

Related Therapies and Procedures

1.	Therapeutics